Evidence map›Paper›PMID 25972144›Full record

ArticleStem cells translational medicine2015

Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4.

Wenbin Liao, Nick Huang, Jingxia Yu, Alexander Jares, Jianchang Yang, Gary Zieve, Cecilia Avila, Xun Jiang, Xiao-Bing Zhang, Yupo Ma

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Functional Comparison of Blood-Derived Human Neural Progenitor Cells.International journal of molecular sciences · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Wenbin LiaoDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA vwliao@gmail.com yupo.ma@stonybrookmedicine.edu.
Nick HuangDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Jingxia YuDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Alexander JaresDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Jianchang YangDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Gary ZieveDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Cecilia AvilaDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Xun JiangDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Xiao-Bing ZhangDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Yupo MaDepartments of Pathology, Surgery, and Obstetrics & Gynecology, Stony Brook University Hospital, Stony Brook University, Stony Brook, New York, USA; Department of Medicine, Loma Linda University, Loma Linda, California, USA vwliao@gmail.com yupo.ma@stonybrookmedicine.edu.
Stony Brook University Hospital · USLoma Linda University · US

Funding

A mouse model of myelodysplastic syndrome progression and leukemic stem cellsR01HL087948 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI MA, YUPO · 2008 to 2012
$2.7M
NHLBI NIH HHS R01 HL087948
6 · The paper itself

Abstract

unlabelled: Cellular reprogramming or conversion is a promising strategy to generate desired stem cell types from somatic cells. Neural stem cells (NSCs) have the potential to regenerate central nervous system tissue and repair damage in response to injury. However, NSCs are difficult to isolate from human tissues and expand in sufficient quantities for therapy. Here, we report a method to generate neural stem cells from cord blood CD34-positive cells by ectopic expression of OCT4 in a feeder-free system. The induced cells (iNSCs) show a characteristic NSC-like morphology and can be expanded in vitro for more than 20 passages. In addition, the iNSCs are positive for neural stem cell-specific markers such as Nestin and Musashi-1 and are similar in gene expression patterns to a human neural stem cell line. The iNSCs express distinct transcriptional factors for forebrain, hindbrain, and spinal cord regions. Upon differentiation, the iNSCs are able to commit into multilineage mature neural cells. Following in vivo introduction into NOD/SCID mice, iNSCs can survive and differentiate in the mouse brain 3 months post-transplantation. Alternatively, we were also able to derive iNSCs with an episomal vector expressing OCT4. Our results suggest a novel, efficient approach to generate neural precursor cells that can be potentially used in drug discovery or regenerative medicine for neurological disease and injury. SIGNIFICANCE: This study describes a novel method to generate expandable induced neural stem cells from human cord blood cells in a feeder-free system by a single factor, OCT4. The data are promising for future applications that require the generation of large amounts of autologous neural stem cells in disease modeling and regenerative medicine.

Indexed as

Cord bloodDirect conversionNeural stem cellOCT4

Identifiers

PMID25972144
PMCPMC4479625
OpenAlexW2112662498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.